Author

Dejana Versamento

University Children's Hospital Zurich

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 2 Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Organism:human· 1 Organism:zebrafish· 1

Frequent Co-Authors

Bernard CirauloiD· 2 shared Dina Hochuli· 2 shared Levi Luca KoppiD· 2 shared Marc Thomas Schönholzer· 2 shared Martin BaumgartneriD· 2 shared Meng-Syuan LiniD· 2 shared Amin AllalouiD· 1 shared Bleiker Tanja· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Bernard CirauloORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MAP4K inhibition by the CNS penetrant inhibitor famlasertib restrains medulloblastoma dissemination without developmental toxicity

Marc Thomas Schönholzer, Meng-Syuan Lin, Shen Yan, Veronica Akle Alvarez, Amin Allalou, Bernard Ciraulo, Dejana Versamento, Levi Luca Kopp, Dina Hochuli, Bleiker Tanja, Welti Annik, Stephan C. F. Neuhauss, Martin Baumgartner

This study shows that famlasertib, a MAP4K inhibitor, reduces medulloblastoma cell invasion in vitro and in zebrafish models without causing developmental toxicity.

bioRxiv · Jul 23, 2026 · PreprintCancer Biology

Fibroblast growth factor receptor substrate 2 interactome mapping reveals novel candidate interactors associated with migration and invasion

Levi Luca Kopp, Dejana Versamento, Bernard Ciraulo, Marc Thomas Schönholzer, Dina Hochuli, Meng-Syuan Lin, Martin Baumgartner

This study maps the FRS2 interactome in medulloblastoma cells, identifying novel proteins involved in cell migration and invasion, and highlights FRS2's role in tumor aggressiveness.

Cell Communication and Signaling · May 21, 2026Peer-reviewedCancer Biology